A blood test prescription specifies precise biological analyses related to a given medical context. Whether this document can be used multiple times at the laboratory depends on what the doctor has written, the reimbursement framework of the Health Insurance, and increasingly, the shift to electronic prescriptions.
Biology prescription: what the laboratory really reads
The laboratory does not just check the date. It examines the list of coded procedures, any mention of renewal, and the consistency between the requested analyses and the clinical reason.
When a doctor prescribes a lipid panel and a fasting blood glucose test on the same prescription, the biologist considers it a single series of tests. Each checked procedure corresponds to a distinct billing line with the Health Insurance. If all procedures are performed on the same day, the prescription is considered executed.
The question of whether one can reuse a blood test prescription arises especially when the doctor has scheduled spaced-out follow-ups, for example, a test in three months and another in six months. In this case, the prescriber must clearly indicate this on the document.
“To renew” mention and prescriptions for extended follow-up
A standard prescription, without any special mention, is valid only once. The laboratory keeps it after execution and sends it to the Health Insurance for reimbursement. Presenting a copy of the same prescription a few weeks later will not work: the billing system detects a procedure that has already been billed.
The situation changes when the doctor includes a mention like “to renew every three months” or “check at M+3 and M+6.” This specification transforms the prescription into a recurring prescription.
The laboratory then agrees to perform the analyses at each scheduled deadline, relying on the same document. However, the total validity period remains limited: a biology prescription is generally valid for twelve months from its date of writing.
- Without a renewal mention, the prescription covers a single series of analyses to be performed within twelve months following the prescription.
- With an explicit periodicity mention (“every three months,” “at M+6”), the laboratory can execute multiple series on the same prescription, within its validity limit.
- For patients with long-term illnesses (ALD), the care protocol may provide for regular biological assessments whose frequency is defined by the treating physician, with appropriate reimbursement.
E-prescription and traceability of biological analyses
The gradual shift to digital prescriptions changes the very logic of reuse. The government prescription of November 18, 2020, established the obligation to generalize electronic prescriptions (e-prescription) for a scope that includes medical biology procedures.
With this system, each prescribed procedure is recorded, dated, and coded in a centralized database. The laboratory no longer scans a paper document: it directly queries the prescription server. When a procedure has been performed, it appears as executed, preventing any unintentional or intentional duplication.
For recurring prescriptions, the doctor schedules the deadlines directly in the software. The laboratory sees the analyses to be performed on the scheduled date, without the patient needing to present a paper.
This operation reduces ambiguities. No need to wonder if the paper prescription “still counts”: the recorded prescription is authoritative, not the physical document.
Laboratory refusal: concrete reasons
A laboratory may refuse to perform analyses on a prescription presented a second time, even if it still seems valid. The most common reasons relate to both the regulatory framework and the responsibility of the biologist.
- The prescription does not include any renewal mention, and the procedures have already been billed: the laboratory cannot bill the same examination twice on the same prescription.
- The prescription date is over twelve months ago: the prescription is considered expired, regardless of the renewal mention.
- The clinical context may have evolved: a biologist may determine that analyses prescribed several months ago no longer correspond to the patient’s situation and recommend a consultation to obtain a new prescription.
- The Health Insurance monitors multiple billings of the same biological procedure on the same prescription, which exposes the laboratory to a risk of reimbursement rejection.
In all these cases, the solution remains the same: consult the prescribing doctor to obtain an updated prescription.
Blood test prescription and reimbursement: the role of the mutual insurance
The Health Insurance reimburses the biological analyses prescribed on a prescription up to its reimbursement base. The remaining part, the co-payment, is covered by the complementary health insurance according to the level of coverage subscribed.
When a recurring prescription generates multiple series of analyses over several months, each visit to the laboratory is billed separately. The reimbursement applies to each series individually, not to the prescription as a whole.
For patients with ALD, coverage can reach the full conventional rate, eliminating the co-payment for analyses related to the specific pathology. The care protocol signed by the treating physician and validated by the Health Insurance precisely defines which examinations are covered and how often.
The answer ultimately lies in a simple distinction: a prescription without a renewal mention is valid only once, while an explicitly recurring prescription allows multiple visits to the laboratory within twelve months. With the generalization of e-prescription, this distinction will be managed directly by the computer system, gradually rendering the question of paper obsolete.